Editorial: Are glucagon‐like peptide‐1 receptor agonists the functional cure for patients with metabolic dysfunction‐associated cirrhosis?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Editorial: Are glucagon‐like peptide‐1 receptor agonists the functional cure for patients with metabolic dysfunction‐associated cirrhosis?

Published:2024-04-23 Issue:10 Volume:59 Page:1286-1287
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Dajti Elton¹²,Rodrigues Susana G.³

Affiliation:

1. Gastroenterology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy

2. Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy

3. Department of Visceral Surgery and Medicine Inselspital, Bern University Hospital, University of Bern Bern Switzerland

Abstract

LINKED CONTENTThis article is linked to Elsaid et al paper. To view this article, visit https://doi.org/10.1111/apt.17925

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17943

Reference10 articles.

1. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

2. The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis

3. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

4. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

5. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP